Woodline Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
1,219,068
+1,194,962
| +4,957% | +$11.2M | 0.06% | 397 |
|
|
2025
Q1 | $171K | Buy |
+24,106
| New | +$171K | ﹤0.01% | 882 |
|
|
2024
Q4 | – | Sell |
-481,752
| Closed | -$9.9M | – | 973 |
|
|
2024
Q3 | $9.9M | Buy |
+481,752
| New | +$9.9M | 0.08% | 293 |
|
|
2023
Q1 | – | Sell |
-498,262
| Closed | -$17.4M | – | 733 |
|
|
2022
Q4 | $17.4M | Buy |
498,262
+150,991
| +43% | +$5.27M | 0.23% | 127 |
|
|
2022
Q3 | $19.4M | Buy |
347,271
+288,610
| +492% | +$16.2M | 0.27% | 103 |
|
|
2022
Q2 | $3.04M | Buy |
+58,661
| New | +$3.04M | 0.05% | 327 |
|